Logo smallSearch

Top-down ban on Ozempic for obesity treatment?

MedExpress Team


Published Oct. 25, 2023 15:52

Top-down ban on Ozempic for obesity treatment? - Header image
Fot. iStock/Getty Images
Belgium plans to temporarily ban the drug Ozempic (semaglutide) for the treatment of obesity. The decision is aimed at preserving the drug's availability for patients with type 2 diabetes.

- [Last month] we appealed to doctors to use this drug only in patients with type 2 diabetes. Today we see that this strategy has not worked," said Franck Vandenbroucke, Belgian Health Minister. - I know that this drug can also be useful in people suffering from pathological obesity, so, of course, we need to talk about it. But I am convinced that we now need to send a stronger message, because simple recommendations are not enough," the ministry chief added.


Content locked

To gain access to the complete English section of the, kindly reach out to us at [email protected].

If you already have an account, please log in



Szukaj nowych pracowników

Dodaj ogłoszenie już za 4 zł dziennie*.

* 4 zł netto dziennie. Minimalny okres ekspozycji ogłoszenia to 30 dni.